RT Journal Article
SR Electronic
T1 Sequence analysis of travel-related SARS-CoV-2 cases in the Greater Geelong region, Australia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.08.20125898
DO 10.1101/2020.06.08.20125898
A1 Bhatta, Tarka Raj
A1 Chamings, Anthony
A1 Liew, Kwee-Chin
A1 Langham, Freya
A1 Gasser, Rudi
A1 Harris, Owen
A1 Gador-Whyte, Andrew
A1 Stenos, John
A1 Athan, Eugene
A1 Alexandersen, Soren
YR 2020
UL http://medrxiv.org/content/early/2020/06/09/2020.06.08.20125898.abstract
AB This study reports the sequence analysis of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from infected individuals within the Greater Geelong region, Victoria, Australia. All but one individual had recently returned from travelling abroad, and all had clinical signs consistent with SARS-CoV-2 infection. SARS-CoV-2 belonging to three lineages were detected and represent separate introductions of the virus into the region. Sequence data were consistent with the recent travel history of each case. Full virus genome sequencing can play an important role in supporting local epidemiological tracing and monitoring for community transmission. Quality of the SARS-CoV-2 sequences obtained was highly dependent on appropriate sample collection and handling.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by Deakin University, Barwon Health and CSIRO and from the National Health and Medical Research Council (NHMRC) equipment grant number GNT9000413 to S.A.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Samples were collected for this study with approval from the Barwon Health Human Research Ethics Committee (Ref HREC 20/56).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the sequences generated have been deposited in GISAID under accession numbers EPI_ISL_420855, EPI_ISL_420876, EPI_ISL_420877 and EPI_ISL_430064 to EPI_ISL_430066. Additional datasets analysed in the paper can be made available from the authors upon reasonable request.